COVID-19 is a virulent, multifaceted viral enemy that has the ability to affect nearly every part of the body from the way he breathes to the way he thinks and now to how he hears. Researchers from King’s College London’s ZOE Covid survey note that more and more people are developing tinnitus as a result of a Covid infection. Study co-founder Professor Tim Spector says the symptoms should be taken “seriously” as they indicate the virus has found new ways to attack the body. Tinnitus occurs when a person is exposed to noise without an external source over a long period; Ringing is the most common form of tinnitus.
Speaking about the development of the new symptoms Professor Spector said: “It turns out that 19 percent, or roughly one in five, have ear problems with Covid, and in our newsletter we got 14,500 to complete the survey and we had about 5,000 tests positive for Covid and it was ringing in the ear.
“What we’ve learned from this is that for just a few days, most people, over 50 percent, said they still had some form of tinnitus that comes and goes and is mild or moderate for weeks or months afterward.
“It was a shock to me; it was something I thought was gone. I got it but it disappeared very quickly.”
Professor Spector now says that tinnitus should be added to the list of symptoms associated with the prolonged illness of Covid.
Read more: Vascular dementia: Symptoms may ‘fluctuate and worsen rapidly’
Nearly two million people are now living with prolonged Covid-19 in the UK; That’s more than one out of 38 people.
Prof Spector said the findings from the ZOE study highlight “the first time that ringing in the ear has been such a prolonged loss of smell…something to be taken seriously as it indicates that a different part of the body is affected, more inward and closed.” brain”.
Furthermore, the professor added that they “hear stories from fellow ENT colleagues that they have seen an increase in referrals for tinnitus after Covid.”
The discovery of increased rates of tinnitus is another achievement of the ZOE Covid study, which has been running since the pandemic began and proven necessary to help track changes in the virus.
do not miss
Although government funding for the study has now been cut as part of the Covid-19 Living plan, the study continues to track how the virus is changing and the ways it affects the body.
Thanks to this study, the list of NHS symptoms was expanded from three to nine earlier this year thanks to this study.
What this latest data provides is yet another insight into the long-running COVID-19 virus, the latest case to join the group of chronic diseases.
Long-Covid, like maternal infection with COVID-19, is unpredictable. Patients report their symptoms varying from day to day.
So far, there is no cure for the long-term Covid virus.
Although there has been no breakthrough in the long-term treatment of Covid disease, scientists have recently identified one way that people can reduce their risk; Get vaccinated.
Researchers from the Office for National Statistics (ONS) recently discovered that those who took two doses of the vaccine were less likely to develop Covid for a prolonged period than those who did not.
Furthermore, they also discovered that the Omicron variant was less likely to cause prolonged Covid than the previously dominant Delta variant.
In a statement, the Office for National Statistics said: “Among the adult study participants who received the dual vaccination, the adjusted sociodemographic prevalence of self-reported Covid four to eight weeks after first infection with delta-compatible coronavirus was 15.9 percent.
“This compared to [over] Eight percent for infections compatible with the Omicron BA.1 variant.
“Among adults who received the triple vaccine, there was no statistical evidence of a difference in the adjusted prevalence of self-reported prolonged Covid-19 between the first infections compatible with the delta variant and those compatible with Omicron BA.1 or Omicron BA.2.
“However, the adjusted prevalence was higher for infections compatible with Omicron BA.2 than for those compatible with Omicron BA.1.”
Read the original article here